Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-10

Clinical Trial Update: The Effect of Amantadine as add-on Therapy for Motor Fluctuations in Advanced Parkinson's Disease: a Randomized Double-blinded Placebo-controlled Trial [Phase 2]

View source ↗

Summary

Phase 2 randomized double-blind trial evaluating amantadine as add-on therapy for motor fluctuations in advanced Parkinson's disease; currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • amantadine (amantadine)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Parkinson Disease (PD) | Phase 2 | Status: NOT_YET_RECRUITING